熱門資訊> 正文

Vir Biotechnology任命Jason O ' Byrne为CFO

2024-09-10 20:32

Vir Biotechnology (NASDAQ:VIR) said it has appointed Jason O’Byrne as its CFO and executive vice president.
The appointment is effective from October 2.
Mr. O’Byrne is an industry veteran with over two decades of experience, and most recently served as the finance chief of Caribou Biosciences.

More on Vir Biotechnology

Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis
Vir announces major restructuring, licensing deal with Sanofi

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。